URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Babak Jahromi

Concepts (252)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Subarachnoid Hemorrhage
10
2003
27
2.830
Why?
Carotid Stenosis
4
2008
52
2.310
Why?
Stroke
7
2006
138
2.270
Why?
Vasospasm, Intracranial
9
2002
10
2.210
Why?
Stents
6
2008
132
1.910
Why?
Basilar Artery
9
2001
10
1.770
Why?
Cerebral Angiography
8
2002
59
1.490
Why?
Carotid Arteries
3
2008
106
1.470
Why?
Muscle, Smooth, Vascular
4
2001
378
1.320
Why?
Balloon Occlusion
2
2008
7
0.870
Why?
Carotid Artery Diseases
3
2003
62
0.810
Why?
Endarterectomy, Carotid
3
2003
32
0.810
Why?
Intracranial Aneurysm
2
2004
21
0.790
Why?
Perfusion Imaging
1
2010
13
0.770
Why?
Blood Vessel Prosthesis
1
2010
31
0.760
Why?
Dogs
10
2001
492
0.750
Why?
Calcium
6
1992
1135
0.740
Why?
Hemostatic Techniques
1
2009
11
0.690
Why?
Subclavian Artery
1
2009
25
0.690
Why?
Evidence-Based Medicine
1
2011
210
0.690
Why?
Neurosurgical Procedures
2
2004
44
0.680
Why?
Myocytes, Smooth Muscle
2
2006
110
0.680
Why?
Large-Conductance Calcium-Activated Potassium Channels
2
2004
9
0.680
Why?
Thromboembolism
1
2009
43
0.680
Why?
Catheters, Indwelling
1
2009
69
0.660
Why?
Embolization, Therapeutic
1
2008
37
0.650
Why?
Patch-Clamp Techniques
7
1999
157
0.650
Why?
Catheterization, Central Venous
1
2009
56
0.650
Why?
Vasoconstriction
1
2008
41
0.640
Why?
Shab Potassium Channels
1
2007
2
0.640
Why?
Vascular Surgical Procedures
1
2008
67
0.630
Why?
Muscle Cells
1
2007
11
0.630
Why?
Potassium
2
2006
309
0.620
Why?
Potassium Channels
2
2004
130
0.610
Why?
Tomography, X-Ray Computed
3
2004
785
0.600
Why?
Clinical Trials as Topic
1
2011
685
0.600
Why?
Hemorrhage
1
2009
181
0.600
Why?
Physician's Practice Patterns
1
2010
268
0.600
Why?
Thrombosis
1
2008
196
0.580
Why?
Postoperative Complications
1
2010
764
0.540
Why?
Time Factors
10
1999
3234
0.520
Why?
Chlamydophila pneumoniae
1
2003
8
0.480
Why?
Aged, 80 and over
7
2003
2588
0.480
Why?
Chlamydia Infections
1
2003
21
0.480
Why?
Treatment Outcome
6
2008
2671
0.440
Why?
Aged
9
2003
7392
0.420
Why?
Hemoglobins
2
2001
95
0.410
Why?
Membrane Potentials
4
1999
343
0.400
Why?
Peroxides
1
2001
18
0.400
Why?
Phosphatidylcholines
1
2001
63
0.390
Why?
Middle Aged
10
2003
10013
0.380
Why?
Nervous System Diseases
2
2011
148
0.370
Why?
Disease Models, Animal
7
2003
974
0.360
Why?
Pyramidal Cells
1
1999
27
0.340
Why?
Humans
18
2001
37165
0.330
Why?
Animals
17
1992
16416
0.320
Why?
Risk Assessment
3
2010
875
0.320
Why?
Intracellular Membranes
2
1992
76
0.310
Why?
Action Potentials
1
1999
256
0.300
Why?
Schwann Cells
2
1992
44
0.290
Why?
Potassium Channels, Inwardly Rectifying
2
2004
23
0.260
Why?
Male
11
1999
20139
0.260
Why?
Cohort Studies
2
2003
984
0.240
Why?
Nitric Oxide Donors
2
2002
22
0.220
Why?
Brain
3
1999
1228
0.220
Why?
Female
12
2002
20222
0.220
Why?
Neurotransmitter Agents
1
1992
48
0.220
Why?
Muscle, Smooth
3
2006
119
0.210
Why?
Neurosciences
1
2012
7
0.210
Why?
Carotid Artery Thrombosis
2
2008
10
0.210
Why?
Specialization
1
2012
43
0.210
Why?
Electric Stimulation
2
1992
227
0.210
Why?
STAT3 Transcription Factor
1
2011
38
0.200
Why?
Critical Care
1
2012
69
0.200
Why?
Synapses
1
1992
110
0.200
Why?
Follow-Up Studies
2
2003
1889
0.200
Why?
Meningeal Neoplasms
1
2011
51
0.190
Why?
Meningioma
1
2011
53
0.190
Why?
Kinetics
2
1999
1471
0.190
Why?
Markov Chains
1
2010
40
0.190
Why?
Health Resources
1
2010
20
0.190
Why?
Neurology
1
2012
91
0.190
Why?
Cell Proliferation
2
2008
520
0.180
Why?
Hospital Costs
1
2010
35
0.180
Why?
Inpatients
1
2010
69
0.180
Why?
RNA, Messenger
5
2004
1893
0.180
Why?
Cost-Benefit Analysis
1
2010
215
0.180
Why?
Angiography, Digital Subtraction
1
2009
20
0.170
Why?
Punctures
1
2009
23
0.170
Why?
Cerebral Revascularization
1
2009
3
0.170
Why?
Thrombolytic Therapy
2
2006
64
0.170
Why?
Organ Culture Techniques
2
2006
99
0.170
Why?
Device Removal
1
2009
31
0.170
Why?
Radiography, Interventional
1
2009
27
0.170
Why?
Intracranial Embolism
1
2009
8
0.170
Why?
Magnetic Resonance Angiography
1
2009
38
0.170
Why?
Aorta, Thoracic
1
2009
71
0.170
Why?
RNA, Ribosomal, 18S
1
2008
4
0.160
Why?
Glyceraldehyde-3-Phosphate Dehydrogenases
1
2008
14
0.160
Why?
Survival Rate
1
2010
619
0.160
Why?
Fatal Outcome
1
2008
109
0.160
Why?
Decompression, Surgical
1
2008
36
0.160
Why?
Electric Conductivity
1
2008
88
0.160
Why?
Catheterization
1
2009
124
0.160
Why?
Survival Analysis
1
2010
589
0.160
Why?
Cells, Cultured
2
2001
2589
0.160
Why?
Prevalence
1
2010
582
0.160
Why?
Feasibility Studies
1
2008
212
0.160
Why?
Diffusion Magnetic Resonance Imaging
1
2009
67
0.160
Why?
Heparin
1
2009
124
0.160
Why?
Reoperation
1
2008
190
0.160
Why?
Prostheses and Implants
1
2008
88
0.160
Why?
Random Allocation
1
2008
253
0.160
Why?
Models, Cardiovascular
1
2008
68
0.160
Why?
Dose-Response Relationship, Radiation
1
2008
216
0.160
Why?
Blotting, Western
2
2004
672
0.150
Why?
Angioplasty, Balloon
1
2008
70
0.150
Why?
Anticoagulants
1
2009
141
0.150
Why?
Endothelin-1
1
2007
26
0.150
Why?
Immunohistochemistry
2
2006
1082
0.150
Why?
Actins
1
2008
214
0.150
Why?
Risk Factors
2
2010
2331
0.140
Why?
Micromanipulation
1
2006
17
0.140
Why?
Isometric Contraction
1
2006
46
0.140
Why?
Infarction, Middle Cerebral Artery
1
2006
16
0.140
Why?
Cyclic GMP
2
2002
76
0.140
Why?
Transducers
1
2006
42
0.140
Why?
Tissue Plasminogen Activator
1
2006
50
0.140
Why?
Fibrinolytic Agents
1
2006
60
0.130
Why?
Neuromuscular Junction
2
1992
38
0.130
Why?
United States
2
2010
2847
0.130
Why?
Gene Expression Regulation
2
2007
895
0.130
Why?
Retrospective Studies
2
2008
2302
0.130
Why?
Adult
6
2002
11572
0.130
Why?
Calcium Channels
1
2006
167
0.130
Why?
Intracranial Thrombosis
1
2004
3
0.130
Why?
Aneurysm, Dissecting
1
2004
19
0.120
Why?
Intracranial Arteriovenous Malformations
1
2004
15
0.120
Why?
Jugular Veins
1
2004
25
0.120
Why?
Magnesium Sulfate
1
2004
11
0.120
Why?
Carotid Artery, Common
1
2004
34
0.120
Why?
Potassium Channels, Voltage-Gated
1
2004
37
0.120
Why?
Triazenes
1
2003
2
0.120
Why?
Blood Vessels
1
2004
93
0.110
Why?
Ion Channels
1
2004
153
0.110
Why?
Protein S Deficiency
1
2002
5
0.110
Why?
Nitroprusside
1
2002
32
0.110
Why?
Neuroprotective Agents
1
2004
125
0.110
Why?
Central Nervous System Vascular Malformations
1
2002
6
0.110
Why?
Craniotomy
1
2002
18
0.110
Why?
Astrocytoma
1
2002
30
0.110
Why?
Magnetic Resonance Imaging
1
2008
1019
0.110
Why?
Inferior Colliculi
1
2002
32
0.110
Why?
Cyclic AMP
1
2003
248
0.100
Why?
Predictive Value of Tests
1
2003
609
0.100
Why?
Dose-Response Relationship, Drug
2
2001
1142
0.100
Why?
Osmolar Concentration
1
2001
159
0.100
Why?
Buffers
1
1999
36
0.090
Why?
Macaca fascicularis
3
2002
84
0.080
Why?
Brain Neoplasms
1
2002
282
0.080
Why?
Angioplasty
2
2009
30
0.080
Why?
Egtazic Acid
1
1999
58
0.080
Why?
Chelating Agents
1
1999
66
0.080
Why?
Dendrites
1
1999
48
0.080
Why?
Coloring Agents
1
1999
57
0.080
Why?
Rats, Wistar
1
1999
164
0.080
Why?
Muscarinic Antagonists
1
1997
13
0.080
Why?
Receptors, Muscarinic
1
1997
33
0.080
Why?
Acetylcholine
1
1997
71
0.080
Why?
Rana pipiens
2
1992
19
0.070
Why?
Barium
2
2006
16
0.070
Why?
Coronary Vasospasm
2
2004
8
0.070
Why?
Young Adult
2
2009
1084
0.070
Why?
Rats
2
1999
4389
0.060
Why?
Blood Pressure
2
2004
468
0.050
Why?
MAP Kinase Kinase 2
1
2011
6
0.050
Why?
Inhibitor of Apoptosis Proteins
1
2011
10
0.050
Why?
MAP Kinase Kinase 1
1
2011
24
0.050
Why?
TOR Serine-Threonine Kinases
1
2011
28
0.050
Why?
Retinoblastoma Protein
1
2011
34
0.050
Why?
Proto-Oncogene Proteins c-sis
1
2011
21
0.050
Why?
Caspase 3
1
2011
91
0.050
Why?
Mitogen-Activated Protein Kinase 3
1
2011
106
0.050
Why?
Platelet-Derived Growth Factor
1
2011
114
0.050
Why?
Immunoblotting
1
2011
225
0.050
Why?
Mitogen-Activated Protein Kinase 1
1
2011
106
0.050
Why?
Proto-Oncogene Proteins c-akt
1
2011
133
0.050
Why?
Health Surveys
1
2012
234
0.050
Why?
Databases as Topic
1
2010
36
0.050
Why?
Adolescent
2
2009
5044
0.050
Why?
DNA Replication
1
2011
207
0.050
Why?
Severity of Illness Index
2
2003
943
0.040
Why?
Thrombectomy
1
2009
15
0.040
Why?
Chi-Square Distribution
1
2010
347
0.040
Why?
Odds Ratio
1
2010
323
0.040
Why?
Length of Stay
1
2010
295
0.040
Why?
Intraoperative Complications
1
2009
61
0.040
Why?
Carotid Artery, Internal
1
2008
31
0.040
Why?
Disease Management
1
2008
31
0.040
Why?
Phosphorylation
1
2011
839
0.040
Why?
Proliferating Cell Nuclear Antigen
1
2008
46
0.040
Why?
Connective Tissue
1
2008
45
0.040
Why?
Tunica Media
1
2008
30
0.040
Why?
Blood Flow Velocity
1
2008
123
0.040
Why?
Logistic Models
1
2010
626
0.040
Why?
TRPC Cation Channels
1
2007
3
0.040
Why?
Indoles
1
2008
104
0.040
Why?
Angiography
1
2007
91
0.040
Why?
Antibodies, Monoclonal
1
2011
748
0.040
Why?
Age Factors
1
2010
1152
0.040
Why?
Electrophysiology
1
2007
249
0.040
Why?
Infusions, Intra-Arterial
1
2006
14
0.040
Why?
Equipment Failure Analysis
1
2006
72
0.030
Why?
Infusions, Intravenous
1
2006
143
0.030
Why?
Stress, Mechanical
1
2006
234
0.030
Why?
Equipment Design
1
2006
253
0.030
Why?
Echoencephalography
1
2004
8
0.030
Why?
Ultrasonography, Doppler, Transcranial
1
2004
12
0.030
Why?
Single-Blind Method
1
2004
121
0.030
Why?
Arteriovenous Shunt, Surgical
1
2004
17
0.030
Why?
Delayed Rectifier Potassium Channels
1
2004
10
0.030
Why?
Potassium Channels, Calcium-Activated
1
2004
12
0.030
Why?
Gene Targeting
1
2004
70
0.030
Why?
Calcium Channels, L-Type
1
2004
48
0.030
Why?
Sensitivity and Specificity
1
2007
914
0.030
Why?
Amino Acid Sequence
1
2007
1227
0.030
Why?
Regional Blood Flow
1
2004
186
0.030
Why?
Middle Cerebral Artery
1
2003
8
0.030
Why?
Cisterna Magna
1
2002
4
0.030
Why?
Injections
1
2002
68
0.030
Why?
Cerebral Arteries
1
2002
40
0.030
Why?
Base Sequence
1
2007
1721
0.030
Why?
Treatment Failure
1
2002
131
0.030
Why?
Signal Transduction
1
2011
1629
0.030
Why?
Up-Regulation
1
2004
375
0.030
Why?
Molecular Sequence Data
1
2007
2046
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
543
0.020
Why?
Rats, Sprague-Dawley
1
2004
1036
0.020
Why?
Prospective Studies
1
2004
1696
0.020
Why?
Muscarine
1
1997
3
0.020
Why?
Nicotinic Antagonists
1
1997
5
0.020
Why?
Gallamine Triethiodide
1
1997
5
0.020
Why?
Xanthenes
1
1997
12
0.020
Why?
Aniline Compounds
1
1997
25
0.020
Why?
Muscarinic Agonists
1
1997
23
0.020
Why?
Nicotinic Agonists
1
1997
10
0.020
Why?
Pertussis Toxin
1
1997
53
0.020
Why?
Virulence Factors, Bordetella
1
1997
55
0.020
Why?
Nicotine
1
1997
34
0.020
Why?
Adenosine
1
1997
90
0.020
Why?
Fluorescent Dyes
1
1997
235
0.020
Why?
Microscopy, Fluorescence
1
1997
277
0.020
Why?

Visualizations


Jahromi's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department